Sig North Trading, Ulc Bausch Health Companies Inc. Call Options Transaction History

Sig North Trading, Ulc

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$7.77 - $10.61 $1.36 Million - $1.86 Million	174,900 Added 85.15%	380,300 $4.03 Million
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $203,016 - $256,344	-26,400 Reduced 11.39%	205,400 $1.69 Million
Q2 2023 Aug 11, 2023	BUY	$5.72 - $8.8 $658,372 - $1.01 Million	115,100 Added 98.63%	231,800 $1.85 Million
Q1 2023 May 16, 2023	SELL	$6.28 - $9.85 $882,968 - $1.38 Million	-140,600 Reduced 54.64%	116,700 $945,000
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $289,884 - $377,468	-47,600 Reduced 15.61%	257,300 $1.62 Million

Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $110,378 - $221,961	24,100 Added 8.58%	304,900 $2.12 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $484,316 - $1.62 Million	68,600 Added 32.33%	280,800 $2.35 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $1.17 Million - $1.51 Million	-54,300 Reduced 20.38%	212,200 $4.91 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $6.13 Million - $7.73 Million	266,500 New	266,500 $7.33 Million

282

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.62B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Sig North Trading, Ulc, based on Form 13F filings with the SEC.

Stay updated on Sig North Trading, Ulc with notifications on news.